HOME ·

Innovative Drugs

CSPC PHARMA (01093.HK): Efmedaglutide Alfa Phase III Data at EASD 2026
Tags：
CSPC PHARMA01093.HKInnovative Drugs
2026-09-30
CSPC PHARMA (01093.HK): JMT206 Phase Ib Obesity Trial Starts in China
Tags：
CSPC PHARMA01093.HKInnovative Drugs
2026-09-29
HANSOH PHARMA (03692.HK): HS-10374 meets co-primary endpoints in Phase III psoriasis trial
Tags：
HANSOH PHARMA03692.HKInnovative Drugs
2026-09-21
Henlius (02696.HK) Serplulimab Approved by EU Commission for First-Line sqNSCLC
Tags：
HENLIUS02696.HKInnovative Drugs
2026-06-25
InSilico (03696.HK): Partnering with Servier on an $888 Million AI-Driven Anti-Tumor Innovative Drug Initiative
Tags：
Insilico03696.HKInnovative Drugs
2026-01-05